Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin

Clinical Transplantation

Volumn 11, Issue 3, 1997, Pages 185-192

  Guttmann, R D ^a   Flemming, C ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Immunosuppression; Renal allograft; Thymoglobuline

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CADAVER DONOR; CHILL; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; FACE EDEMA; FEMALE; FEVER; GRAFT FAILURE; GRAFT SURVIVAL; HEADACHE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INJECTION PAIN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LIVING DONOR; LUNG EDEMA; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MENINGISM; METABOLIC DISORDER; MUSCLE HYPERTONIA; NAUSEA; NECK INJURY; ORAL DRUG ADMINISTRATION; PREVALENCE; PRIORITY JOURNAL; RASH; SURVIVAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ACTUARIAL ANALYSIS; ADULT; ANIMALS; ANTILYMPHOCYTE SERUM; AZATHIOPRINE; CADAVER; COHORT STUDIES; CREATININE; CYCLOSPORINE; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; LEUKOPENIA; LIVING DONORS; LYMPHOCYTES; MALE; MENINGISM; METHYLPREDNISOLONE; MIDDLE AGED; RABBITS; RECURRENCE; RETREATMENT; SURVIVAL RATE;

EID: 0030920481     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. STARZL TE, MURCHORIO TL, PORTER KA, IWATSAKI Y, CERELLI GJ. The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet 1967: 124: 301.
2. GUTTMANN RD. Renal Transplantation - Medical Progress. N Engl JMed 1979: 301: 975: 301: 1038.
3. GRUBER SA, CHAN GLC, CANAFAX DM, et al. Immunosuppression in renal transplantation. II. Corticosteroids, antilymphocyte globlin, and OKT3. Clin Trans 1991: 5: 219.
4. KUPIN WL, KUMARAPURAM KV, HEUNG KO, et al. Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric renal transplantation. Transplantation 1985: 40: 601.
5. HARDY MA, NOWYGRAD R, ELBERG G, et al. Use of ATG in the treatment of steroid-resistant rejection. Transplantation 1980: 29: 162.
6. FILO RS, SMITH EJ, LEAPMAN SB. Reversal of acute cadaveric renal allograft rejection with adjunctive ATG therapy. Transplant Proc 1981: 13: 482.
7. NELSON PW, COSIMI AB, DELMONICO FL, et al. Anti-lymphocyte globulin as the primary treatment for renal allograft rejection. Transplantation 1983: 36: 587.
8. BOURDAGE JS, HAMLIN DM. Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry. Transplantation. 1995: 59: 1194.
9. Ortho Multicenter Transplant Study Group. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 1985: 313: 337.
10. HANTO DW, JENDRISAK MD, So SKS, et al. Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Transplantation 1994: 57: 377.
11. NAJARIAN JS, FRYD DS, STRAND M, et al. A single institution, randomized, prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Ann Surg 1985: 201: 142.
12. SUTHERLAND DER, FRYD DS, STRAND MH, et al. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-lymphocyte globulin for immunosuppression in renal allograft recipients. Am J Kid Dis 1985: 5: 318.
13. STRATTA RJ, D'ALESSANDRO AM, ARMBRUST MJ, et al. Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Transplantation 1989: 47: 96.
14. GRINO JM, ALSINA J, SABATER R, et al. Antilymphoblast globulin, cyclosporine, and steroids in cadaveric renal transplantation. Transplantation 1990: 49: 1114.
15. DIETHELM AG, BLACKSTONE E, PASS RF, et al. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation. Transpl Proc 1979: 11: 27.
16. COLE EH, CATTRAN DC, FAREWELL VT, et al. A comparison of rabbit antithymocyte serum and OKT3 as prophylaxis against renal allograft rejection. Transplantation 1994: 57: 50.
17. FREY, DJ, MATAS, AJ, GILLINGHAM, KJ, et al. Sequential therapy-A prospective randomized trial of malg versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients. Transplantation 54: 50-56, 1992.
18. BONNEFORY-BÉRARD N, VINCENT C, REVILLARD JP. Antibodies against functional leucocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulin. Transplantation 1991: 51: 669.
19. REBELLATO LM, GROSS U, VERBANAC KM, et al. A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin. Transplantation 1994: 57: 685.
20. BOCK P, HOBLER N, CAUDRELIER P, et al. Treatment of acute rejection in renal graft recipients by Thymoglobuline: A retrospective multicenter analysis. Transpl Proc 1995: 27: 1058.
21. LAUFER G, LACZKOVICS A, WOLLENEK G, et al. Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine-and azathioprine-immunosuppressed cardiac allografts. J Heart Transpl 1989: 8: 253.
22. KORMOS RL, ARMITAGE JM, DUMMER JS, et al. Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin. Transplantation 1990: 49: 306.
23. CARRIER M, PELLETIER GB, CARTIER R. et al. Induction of immunosuppression with rabbit antithymocyte globulin: Five-year experience in cardiac transplantation. Can J Cardiol 1993: 9: 171.
24. IPPOLITI G, NEGRI M, ABELLI P, et al. Preoperative prophylactic OKT3 vs RATG. A randomized clinical study in heart transplant patients. Transpl Proc 1991: 23: 2272.
25. IPPOLITI G, ROVATI B, GRAFFIGNA A, et al. Prophylactic use of rabbit ATG vs horse ALG in heart-transplanted patients under Sandimmun (CyA) therapy: Clinical and immunological effects. Clin Transpl 1989: 3: 204.
26. BERGLIN E, BERGGREN H, NILSSON F, et al. Immunosuppression with or without ATG in heart transplantation. Transpl Proc 1994: 26: 1811.
27. SOULILLOU J-P, CANTAROVICH D, LE MAUFF B, et al. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts. N Engl J Med 1990: 322: 1175.